Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

188 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer.
Schöttle J, Chatterjee S, Volz C, Siobal M, Florin A, Rokitta D, Hinze Y, Dietlein F, Plenker D, König K, Albus K, Heuckmann JM, Rauh D, Franz T, Neumaier B, Fuhr U, Heukamp LC, Ullrich RT. Schöttle J, et al. Among authors: Fuhr U. Oncotarget. 2015 Nov 17;6(36):38458-68. doi: 10.18632/oncotarget.6276. Oncotarget. 2015. PMID: 26540572 Free PMC article.
Clinical pharmacokinetics of trospium chloride.
Doroshyenko O, Jetter A, Odenthal KP, Fuhr U. Doroshyenko O, et al. Among authors: Fuhr U. Clin Pharmacokinet. 2005;44(7):701-20. doi: 10.2165/00003088-200544070-00003. Clin Pharmacokinet. 2005. PMID: 15966754 Review.
Assessment of CYP1A2 activity in clinical practice: why, how, and when?
Faber MS, Jetter A, Fuhr U. Faber MS, et al. Among authors: Fuhr U. Basic Clin Pharmacol Toxicol. 2005 Sep;97(3):125-34. doi: 10.1111/j.1742-7843.2005.pto_973160.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 16128905 Review.
Population pharmacokinetics of the BEACOPP polychemotherapy regimen in Hodgkin's lymphoma and its effect on myelotoxicity.
Wilde S, Jetter A, Rietbrock S, Kasel D, Engert A, Josting A, Klimm B, Hempel G, Reif S, Jaehde U, Merkel U, Busse D, Schwab M, Diehl V, Fuhr U. Wilde S, et al. Among authors: Fuhr U. Clin Pharmacokinet. 2007;46(4):319-33. doi: 10.2165/00003088-200746040-00005. Clin Pharmacokinet. 2007. PMID: 17375983 Clinical Trial.
188 results
Jump to page
Feedback